Remedy: Increase your bets before the AWR release

By Atte Riikola
Remedy's strategy and game projects are progressing decisively and the visibility of the growth drivers for coming years has strengthened this year. At the same time, the company's share has remained stagnate, which we believe provides long-term investors a good place to buy before the growth leap from new game releases. As a short-term positive driver, we see the launch of the Alan Wake Remastered game (AWR) on October 5, which is very likely to be a profitable project for Remedy.